Table 2.
Predictor variables of all-cause mortality in the model
| Variables | Survive (n = 1573) | Death (n = 223) | P |
|---|---|---|---|
| Age, years | 72 (63, 79) | 77 (71, 82) | < 0.001 |
| BMI, kg/m2 | 24.34(22.23,27.00) | 23.52(20.83,25.95) | < 0.001 |
| DBP, mmHg | 80 (70,86) | 76 (70, 84) | 0.01 |
| WBC,109/L | 6.60 (5.30, 7.80) | 7.00 (5.80, 8.60) | < 0.001 |
| Hemoglobin, g/L | 135 (125, 150) | 129 (118, 142) | < 0.001 |
| RDW, % | 14.1 (13.54, 14.56) | 14.5 (13.93, 15.26) | < 0.001 |
| AST, U/L | 23.00 (21.00, 24.00) | 25.00 (21.00, 39.00) | < 0.001 |
| Albumin, U/L | 42.00 (39.80, 45.40) | 40.00 (37.00, 43.00) | < 0.001 |
| TBIL, umol/L | 16.50 (12.70, 20.20) | 20.20 (14.60, 22.80) | < 0.001 |
| ALP, U/L | 76 (64, 88) | 76 (64, 97) | 0.029 |
| BUN, mmol/L | 6.50 (5.19, 8.20) | 7.81 (5.80,10.20) | < 0.001 |
| CyscGFR, ml/min/1.73m2 | 57.70(51.25,69.77) | 46.40(38.69,61.03) | < 0.001 |
| Uric acid, umol/L | 399.0 (327.0, 470.0) | 457.0 (350.0, 523.0) | < 0.001 |
| NT-proBNP, ng/L | 2201(983, 3293) | 4563 (2201,7532) | < 0.001 |
| QRS, ms | 98 (88, 116) | 106 (90, 130) | < 0.001 |
| LVEF, % | 50 (40, 59) | 45 (38, 56) | < 0.001 |
| NYHA class, n (%) | |||
| II | 560 (97.56) | 14 (2.44) | < 0.001 |
| III or IV | 1013(82.90) | 209 (17.10) | |
| COPD n (%) | |||
| No | 1242 (91.06) | 122(8.94) | < 0.001 |
| Yes | 331 (76.62) | 101 (23.38) | |
| Diabetes n (%) | |||
| No | 1148 (89.48) | 135 (10.52) | < 0.001 |
| Yes | 425 (82.85) | 88 (17.15) | |
| ACEI/ARB, n (%) | |||
| Yes | 763 (89.34) | 91(10.66) | 0.031 |
| No | 810 (85.99) | 132 (14.01) | |
| Beta-blockers, n (%) | |||
| Yes | 1112 (91.67) | 101 (8.33) | < 0.001 |
| No | 461 (79.07) | 122 (20.93) |
Data are presented as median (interquartile range) or n (%)
BMI: body mass index, DBP: diastolic blood pressure, WBC: white blood cell, RDW: red blood cell distribution width, ALT: alanine aminotransferase, AST: aspartate aminotransferase, TBIL: total bilirubin, BUN: blood urea nitrogen, ALP: alkaline phosphatase, CyscGFR: estimated glomerular filtration rate was calculated by cystatin C, NT-proBNP: N-terminal pro-brain natriuretic peptide, LVEF: left ventricular ejection fraction, NYHA: New York Hearth Association, COPD: chronic obstructive pulmonary disease, ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker